We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05065970
Brief Title: Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy (IGNAZ)

First Submitted : September 14, 2021
First Submitted that Met QC Criteria : September 23, 2021
First Posted : October 4, 2021

Last Update Submitted that Met QC Criteria : December 12, 2022
Last Update Posted : December 13, 2022